Anesthetic Treatment of Cardiac Disease During Pregnancy
Purpose of review This review summarizes the pathophysiology, peripartum treatment, and anesthetic management of parturients with cardiac disease. Valvular disease, coronary disease, and cardiomyopathy are specifically addressed in the context of the normal physiologic changes of pregnancy. We offer recommendations for anesthetic approaches, hemodynamic goals with an emphasis on interdisciplinary planning between anesthesiologists, cardiologists, cardiothoracic surgeons, obstetricians, maternal fetal medicine specialists, and neonatologists. Recent findings Vaginal delivery with neuraxial analgesia can be well tolerated by many pregnant patients with cardiac disease when coordinated by an interdisciplinary team of experts. Summary Cardiac disease in pregnancy can present a significant challenge for the interdisciplinary care team. A detailed understanding of each patient’s cardiac pathology and the physiologic changes of pregnancy are critical to ensure a safe and successful labor and delivery. Optimized medical therapy in the peripartum period and neuraxial anesthesia with the judicious use of vasoactive agents can be of great benefit for these parturients. As is generally the case, cesarean delivery should be primarily reserved for obstetric indications and maternal wellbeing, with careful consideration of the fetus to guide best practices..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Current treatment options in cardiovascular medicine - 20(2018), 8 vom: 18. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cohen, Kate M. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Cardiac disease |
| doi: |
10.1007/s11936-018-0657-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR023064315 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR023064315 | ||
| 003 | DE-627 | ||
| 005 | 20230519140755.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11936-018-0657-4 |2 doi | |
| 035 | |a (DE-627)SPR023064315 | ||
| 035 | |a (SPR)s11936-018-0657-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Cohen, Kate M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anesthetic Treatment of Cardiac Disease During Pregnancy |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Purpose of review This review summarizes the pathophysiology, peripartum treatment, and anesthetic management of parturients with cardiac disease. Valvular disease, coronary disease, and cardiomyopathy are specifically addressed in the context of the normal physiologic changes of pregnancy. We offer recommendations for anesthetic approaches, hemodynamic goals with an emphasis on interdisciplinary planning between anesthesiologists, cardiologists, cardiothoracic surgeons, obstetricians, maternal fetal medicine specialists, and neonatologists. Recent findings Vaginal delivery with neuraxial analgesia can be well tolerated by many pregnant patients with cardiac disease when coordinated by an interdisciplinary team of experts. Summary Cardiac disease in pregnancy can present a significant challenge for the interdisciplinary care team. A detailed understanding of each patient’s cardiac pathology and the physiologic changes of pregnancy are critical to ensure a safe and successful labor and delivery. Optimized medical therapy in the peripartum period and neuraxial anesthesia with the judicious use of vasoactive agents can be of great benefit for these parturients. As is generally the case, cesarean delivery should be primarily reserved for obstetric indications and maternal wellbeing, with careful consideration of the fetus to guide best practices. | ||
| 650 | 4 | |a Obstetric anesthesia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cardiac disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Valvular disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Peripartum cardiomyopathy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Labor analgesia |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Minehart, Rebecca D. |e verfasserin |4 aut | |
| 700 | 1 | |a Leffert, Lisa R. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current treatment options in cardiovascular medicine |d Philadelphia, Pa. : Current Science Inc., 1999 |g 20(2018), 8 vom: 18. Juli |w (DE-627)SPR023056592 |w (DE-600)2090727-8 |x 1534-3189 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2018 |g number:8 |g day:18 |g month:07 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11936-018-0657-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.85 |q ASE |
| 951 | |a AR | ||
| 952 | |d 20 |j 2018 |e 8 |b 18 |c 07 | ||